Assessing interactions between HLA-DRB1*15 and Epstein-Barr

Discuss topics relevant to gene therapy for MS here

Assessing interactions between HLA-DRB1*15 and Epstein-Barr

Postby MSUK » Wed Feb 20, 2013 2:40 am

Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis

Summary: This study from the UK looked at gene-environment interactions in MS.

The researchers looked at the interaction between HLA-DRB1*15 (DRB1-15) and history of infectious mononucleosis (IM). They found that individuals exposed to both factors were at an increased risk of disease. Both DRB1-15 and IM status were independent predictors of disease, while there interaction term was not, but interaction on an additive scale was evident.

Based on this, if the additive model is appropriate, the DRB1-15 and IM may be part of the causal process leading to MS. This study demonstrates the importance of reporting gene-environment interactions on both a multiplicative and additive scale.... Read More - http://www.ms-uk.org/index.cfm/viralcauses
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2121
Joined: Wed Oct 14, 2009 3:00 pm

Return to Gene Therapy

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service

cron